News

Why Exponent (EXPO) Might be Well Poised for a Surge

  • Exponent (EXPO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
    04/30/2024

Exponent, Inc. (EXPO) Q1 2024 Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q1 2024 Earnings Conference Call April 25, 2024 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Maxwell - William Blair Josh Chan - UBS Jack Wilson - Truist Operator Good afternoon and welcome to the Exponent, Inc. Quarter One 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
    04/25/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Exponent, Inc. (EXPO) can buy. Click on Rating Page for detail.

The price of Exponent, Inc. (EXPO) is 96.77 and it was updated on 2024-05-21 01:13:09.

Currently Exponent, Inc. (EXPO) is in overvalued.

News
    
News

Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates

  • Exponent (EXPO) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.56 per share a year ago.
    Thu, Apr. 25, 2024

Exponent Declares Regular Quarterly Dividend for Q2 2024

  • MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on June 21, 2024 to all common stockholders of record as of June 7, 2024.
    Thu, Apr. 25, 2024

Exponent Reports First Quarter 2024 Financial Results

  • MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2024 ended March 29, 2024.
    Thu, Apr. 25, 2024

Exponent to Announce First Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on April 25, 2024

  • MENLO PARK, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2024 financial results for the period ended March 29, 2024 following the close of the market on Thursday, April 25, 2024. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
    Tue, Apr. 09, 2024

27 Upcoming Dividend Increases Including A Dividend King

  • A new list of 27 new dividend increases, including King Kimberly-Clark and three other champions.
    Thu, Feb. 29, 2024
SEC Filings
SEC Filings

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/16/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/07/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/06/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/03/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/30/2024

Exponent, Inc. (EXPO) - DEFA14A

  • SEC Filings
  • 04/22/2024

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/22/2024

Exponent, Inc. (EXPO) - ARS

  • SEC Filings
  • 04/22/2024

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 04/10/2024

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 03/25/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/19/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/16/2024

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/13/2024

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/12/2024

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/12/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/12/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/09/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/08/2024

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/23/2024

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/05/2024

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/27/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/24/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/22/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/18/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/15/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/09/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/24/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/22/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/12/2023

Exponent, Inc. (EXPO) - DEFA14A

  • SEC Filings
  • 04/25/2023

Exponent, Inc. (EXPO) - ARS

  • SEC Filings
  • 04/25/2023

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/24/2023

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 04/10/2023

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 04/06/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/17/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/14/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/24/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/21/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/17/2023

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 02/17/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/16/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/15/2023

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/14/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/14/2023

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/13/2023

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2023

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/09/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/08/2023

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/26/2023

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/20/2023

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/18/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/07/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/23/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/16/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/10/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/09/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/06/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/03/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/27/2022

Exponent, Inc. (EXPO) - DEFA14A

  • SEC Filings
  • 04/20/2022

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/20/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/11/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/17/2022

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/11/2022

Exponent, Inc. (EXPO) - SC 13G

  • SEC Filings
  • 02/11/2022

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/11/2022

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/09/2022

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/27/2022

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/25/2022

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/21/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/15/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/12/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/09/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/01/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/31/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/26/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/24/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/19/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/16/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/11/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/06/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/05/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/07/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/04/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/02/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/01/2021

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 05/27/2021

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/21/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/16/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/02/2021

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/12/2021

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/12/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/12/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/11/2021

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2021

Exponent, Inc. (EXPO) - SC 13G

  • SEC Filings
  • 01/25/2021

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/18/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/11/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/08/2020

Exponent, Inc. (EXPO) - UPLOAD

  • SEC Filings
  • 12/04/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/01/2020

Exponent, Inc. (EXPO) - CORRESP

  • SEC Filings
  • 11/25/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/25/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/20/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/18/2020

Exponent, Inc. (EXPO) - UPLOAD

  • SEC Filings
  • 11/17/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/12/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/05/2020

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 11/02/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/26/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/24/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/12/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/06/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/29/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/25/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/19/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/16/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/11/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/08/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/03/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/29/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/28/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/21/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/08/2020

Exponent, Inc. (EXPO) - DEFA14A

  • SEC Filings
  • 05/06/2020

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/15/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/17/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/13/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/27/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/25/2020

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/14/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/14/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/13/2020

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/12/2020

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/04/2020

Exponent, Inc. (EXPO) - SC 13G

  • SEC Filings
  • 01/17/2020

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 01/14/2020

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/23/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/17/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/11/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/09/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/03/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/25/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/22/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/19/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/14/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/08/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/06/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/31/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/28/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/24/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/26/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/23/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/21/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/15/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/12/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/03/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/30/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/08/2019

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/16/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/18/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2019

Exponent, Inc. (EXPO) - 5/A

  • SEC Filings
  • 02/26/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/26/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/22/2019

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/19/2019

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/13/2019

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/11/2019

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/11/2019

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/28/2019

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 12/10/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/07/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/29/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/13/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/02/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/04/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/29/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/22/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/16/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/14/2018

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 05/11/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/11/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/09/2018

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/17/2018

Exponent, Inc. (EXPO) - PRE 14A

  • SEC Filings
  • 04/06/2018

Exponent, Inc. (EXPO) - S-8

  • SEC Filings
  • 03/19/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/12/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/20/2018

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/15/2018

Exponent, Inc. (EXPO) - 5/A

  • SEC Filings
  • 02/15/2018

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/12/2018

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/09/2018

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/09/2018

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/23/2018

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/27/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/03/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/28/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/25/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/19/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/14/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/12/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/07/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/01/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/28/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/23/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/18/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/16/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/11/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/08/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/03/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/25/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/02/2017

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/18/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/17/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/14/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/17/2017

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 02/16/2017

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/14/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/14/2017

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/13/2017

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2017

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/09/2017

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/12/2017

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/14/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/10/2016

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 11/09/2016

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 10/26/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/26/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/24/2016

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 10/11/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/16/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/04/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/01/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/27/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/18/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/08/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/01/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/28/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/23/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/16/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/13/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/07/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/01/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/27/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/25/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/24/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/20/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/18/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/13/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/11/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/26/2016

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/13/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/14/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/11/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/26/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/24/2016

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 02/19/2016

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 02/17/2016

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/17/2016

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/16/2016

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/12/2016

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2016

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/09/2016

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/26/2016

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 12/17/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/12/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/05/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/30/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/28/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/01/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/29/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/22/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/21/2015

Exponent, Inc. (EXPO) - UPLOAD

  • SEC Filings
  • 09/17/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/16/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/09/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/31/2015

Exponent, Inc. (EXPO) - CORRESP

  • SEC Filings
  • 08/24/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/21/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/18/2015

Exponent, Inc. (EXPO) - UPLOAD

  • SEC Filings
  • 08/17/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/13/2015

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 08/11/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/07/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/04/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/27/2015

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 06/09/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/01/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/27/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/22/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/08/2015

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/16/2015

Exponent, Inc. (EXPO) - PRE 14A

  • SEC Filings
  • 04/06/2015

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 04/06/2015

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 04/03/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/17/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/13/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/02/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/17/2015

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/13/2015

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/12/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/12/2015

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/11/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/11/2015

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 02/06/2015

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/05/2015

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/22/2015

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 01/15/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 01/08/2015

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/03/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/29/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 09/03/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/29/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/06/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/29/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/26/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/25/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/19/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/17/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/11/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/06/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/03/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/02/2014

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 06/02/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/30/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/28/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/27/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/21/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/16/2014

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 05/12/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/12/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/07/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/05/2014

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/16/2014

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 03/19/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/18/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/14/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/04/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/24/2014

Exponent, Inc. (EXPO) - 5/A

  • SEC Filings
  • 02/14/2014

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/14/2014

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/13/2014

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/12/2014

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/11/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/11/2014

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/29/2014

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/27/2014

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/13/2014

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/13/2013

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 12/13/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/22/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/20/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/29/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/23/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/26/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/23/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/14/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/12/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/08/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/05/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/02/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/30/2013

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 06/17/2013

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 06/03/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/31/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/23/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/10/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/03/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/23/2013

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/17/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/19/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 03/08/2013

Exponent, Inc. (EXPO) - 4/A

  • SEC Filings
  • 02/22/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/21/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/20/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/14/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/13/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/11/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/08/2013

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/08/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/05/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/05/2013

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/08/2013

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/21/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/18/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/12/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/10/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/06/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/04/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/30/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/26/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/20/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/15/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/09/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/07/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/05/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/02/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/30/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/25/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/24/2012

Exponent, Inc. (EXPO) - S-8

  • SEC Filings
  • 09/24/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/24/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 08/08/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/31/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/27/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/25/2012

Exponent, Inc. (EXPO) - 3

  • SEC Filings
  • 06/13/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/01/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/04/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/01/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/26/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/25/2012

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/19/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/13/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/09/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/03/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/28/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/21/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/16/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/12/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/06/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/29/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/27/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/23/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/16/2012

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/14/2012

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/14/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/14/2012

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/13/2012

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/10/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/10/2012

Exponent, Inc. (EXPO) - SC 13G

  • SEC Filings
  • 02/09/2012

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/09/2012

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/08/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/07/2012

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 01/11/2012

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/28/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/22/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/14/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/09/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/06/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 12/01/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/29/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/17/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/10/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/07/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 11/03/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/31/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/27/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 10/25/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/29/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 07/27/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 06/02/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/26/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 05/12/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/29/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 04/28/2011

Exponent, Inc. (EXPO) - DEF 14A

  • SEC Filings
  • 04/20/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/15/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 03/11/2011

Exponent, Inc. (EXPO) - 5/A

  • SEC Filings
  • 02/24/2011

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/24/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/16/2011

Exponent, Inc. (EXPO) - 5

  • SEC Filings
  • 02/15/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/15/2011

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/14/2011

Exponent, Inc. (EXPO) - SC 13G

  • SEC Filings
  • 02/11/2011

Exponent, Inc. (EXPO) - 4

  • SEC Filings
  • 02/08/2011

Exponent, Inc. (EXPO) - SC 13G/A

  • SEC Filings
  • 02/04/2011
Press Releases
StockPrice Release
More Headlines
News

Why Exponent Stock Is Falling Today

  • Exponent missed on fourth-quarter earnings and warned revenue would be flat to down slightly in 2024. The consulting firm has seen customers delay, slowing revenue.
  • 02/02/2024

Exponent, Inc. (EXPO) Q4 2023 Earnings Call Transcript

  • Exponent, Inc. (EXPO) Q4 2023 Earnings Call Transcript
  • 02/01/2024

Exponent Increases Quarterly Dividend Payment from $0.26 to $0.28 per Share for Q1 2024, Increases Stock Repurchase Authorization to $100 Million

  • MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.26 to $0.28 per share of common stock. The quarterly cash dividend of $0.28 per share of common stock is to be paid on March 22, 2024 to all common stockholders of record as of March 8, 2024.
  • 02/01/2024

Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results

  • MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2023 ended December 29, 2023.
  • 02/01/2024

Exponent to Announce Fourth Quarter and Fiscal Year 2023 Results and Host Quarterly Conference Call on February 1, 2024

  • MENLO PARK, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2023 financial results for the period ended December 30, 2023 following the close of the market on Thursday, February 1, 2024. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 01/11/2024

Exponent Inc. (EXPO) Q3 2023 Earnings Call Transcript

  • Exponent Inc. (NASDAQ:EXPO ) Q3 2023 Results Conference Call October 26, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Corrigan - President, CEO and Director Rich Schlenker - Executive VP, CFO and Corporate Secretary Conference Call Participants Tobey Sommer - Truist Josh Chan - UBS Andrew Nicholas - William Blair Operator Good day, and welcome to the Exponent Third Quarter Fiscal Year 2023 Earnings Conference Call. All participants will be in a listen-only mode.
  • 10/26/2023

Exponent (EXPO) Q3 Earnings and Revenues Lag Estimates

  • Exponent (EXPO) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.47 per share a year ago.
  • 10/26/2023

Exponent Declares Regular Quarterly Dividend

  • MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on December 22, 2023 to all common stockholders of record as of December 8, 2023.
  • 10/26/2023

Exponent Reports Third Quarter of Fiscal Year 2023 Financial Results

  • MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2023 ended September 29, 2023.
  • 10/26/2023

Exponent to Announce Third Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on October 26, 2023

  • MENLO PARK, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2023 financial results for the period ended September 29, 2023 following the close of the market on Thursday, October 26, 2023. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 10/05/2023

Exponent: Highly Profitable Business With A Wide Moat

  • Exponent's revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services to its clients, leveraging decades of experience and data. Further, it has developed deep expertise within specific high-value, robust industries, such as healthcare. Global megatrends such as technological development and growing investment in healthcare and chemicals have the potential to maintain or enhance Exponent's growth trajectory.
  • 09/29/2023

Exponent, Inc. (EXPO) Q2 2023 Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Josh Chan - UBS Tobey Sommer - Truist Operator Good day. And welcome to the Exponent's Second Quarter Earnings Conference Call.
  • 07/27/2023

Exponent (EXPO) Lags Q2 Earnings and Revenue Estimates

  • Exponent (EXPO) came out with quarterly earnings of $0.50 per share, missing the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.49 per share a year ago.
  • 07/27/2023

Exponent to Announce Second Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on July 27, 2023

  • MENLO PARK, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2023 financial results for the period ended June 30, 2023 following the close of the market on Thursday, July 27, 2023. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 07/06/2023

Can Consulting Services Industry Maintain Pace in 2H 2023?

  • At this stage, several consulting services stocks look attractive for future growth. These are: HURN, EXPO, CBZ, FC, FCN.
  • 06/29/2023

Is the Options Market Predicting a Spike in Exponent (EXPO) Stock?

  • Investors need to pay close attention to Exponent (EXPO) stock based on the movements in the options market lately.
  • 06/29/2023

Exponent: High Quality At A High Price

  • EXPO has been a great growth story over the long run. Capital allocation will matter more at this stage of the company's life cycle. The quality is priced in and then some.
  • 06/15/2023

3 Stocks to Buy From the Booming Consulting Services Industry

  • With service activities remaining healthy, the Zacks Consulting Services industry is poised to prosper. EXPO, CBZ and HURN are three stocks that are well-placed to ride the demand strength.
  • 06/08/2023

Exponent to Present at Upcoming Investor Conferences

  • MENLO PARK, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Company management will present to the investment community at two upcoming investor conferences:
  • 05/31/2023

Exponent, Inc. (EXPO) Q1 2023 Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Securities Operator Good afternoon. And welcome to the Exponent First Quarter 2023 Earnings Conference Call.
  • 04/29/2023

Exponent (EXPO) Q1 Earnings Meet Estimates

  • Exponent (EXPO) came out with quarterly earnings of $0.56 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.56 per share a year ago.
  • 04/27/2023

Exponent to Announce First Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on April 27, 2023

  • MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2023 financial results for the period ended March 31, 2023 following the close of the market on Thursday, April 27, 2023. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 04/03/2023

Dividend Champion, Contender, And Challenger Highlights: Week Of March 19

  • A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
  • 03/19/2023

32 Upcoming Dividend Increases Including 2 Dividend Kings

  • All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.3% and a median increase of 8.1%.
  • 03/02/2023

Walmart, Home Depot Among 15 Companies To Announce Dividend Increases In Second Half Of February

  • When it comes to annual dividend increases, February is the highlight of the year. There were at least 27 dividend boosts that were announced from a wide variety of companies. Widely held companies 3M, PepsiCo, and Coca-Cola all boosted their dividends in the first half of the month, with Pepsi announcing a 10% increase.
  • 02/19/2023

EXPO Stock: 5.51% Increase Explained

  • The stock price of Exponent Inc (NASDAQ: EXPO) increased by 5.51% in the most recent trading session. This is why.
  • 02/05/2023

Exponent, Inc. (EXPO) Q4 2022 Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q4 2022 Results Conference Call February 2, 2023 4:30 PM ET Company Participants Joni Konstantelos - IR Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Operator Good day, and welcome to Exponent's Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen only mode [Operator Instructions].
  • 02/02/2023

3 Dividend Kings Among 22 Companies To Announce Annual Dividend Increases In First Half Of February

  • There is a slew of dividend increases coming in February, including from dividend kings Genuine Parts, 3M, and PepsiCo in the first half of the month. Other popular stocks that traditionally announce annual increases in early February are Sherwin-Williams and Cisco.
  • 01/29/2023

Exponent to Announce Fourth Quarter and Fiscal Year 2022 Results and Host Quarterly Conference Call on February 2, 2023

  • MENLO PARK, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report fourth quarter and fiscal year 2022 financial results for the period ended December 30, 2022 following the close of the market on Thursday, February 2, 2023. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 01/12/2023

Exponent: Entering Back Into Buy Range, If Sentiment Holds

  • Exponent is a leading consulting firm, an area of the market with stable and quality performance assets. Unfortunately, EXPO's valuation got ahead of itself and I sold in late 2021.
  • 11/18/2022

Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 11.90% and 1%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 10/27/2022

Exponent, Inc. (EXPO) Q3 2022 Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer & Corporate Secretary Conference Call Participants Operator Good day and welcome to the Exponent, Incoporated Third Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded.
  • 10/27/2022

Exponent to Announce Third Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on October 27, 2022

  • MENLO PARK, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report third quarter of fiscal year 2022 financial results for the period ended September 30, 2022 following the close of the market on Thursday, October 27, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 10/06/2022

The 5 Smartest Investments In The Market

  • Retail investors are often at a disadvantage, but one simple way to win is by investing in the "smartest" companies. This article will present five companies that I believe are the smartest and explain why.
  • 09/23/2022

India's Exponent Energy may have found the secret to 15 min rapid EV charging

  • Bangalore-based Exponent Energy might have come up with a way to deliver 15-minute rapid charging for electric vehicles. The startup, which just raised a $13 million Series A, relies on a combination of its proprietary battery pack and charging infrastructure to achieve such a feat.
  • 08/17/2022

Exponent, Inc. (EXPO) CEO Catherine Ford Corrigan on Q2 2022 Results - Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q2 2022 Results Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations, Clermont Partners Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer and Corporate Secretary Conference Call Participants Tobey Sommer - Truist Securities Operator Good day and welcome to the Exponent, Inc. Second Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded.
  • 07/28/2022

Exponent (EXPO) Q2 Earnings Surpass Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 8.89% and 0.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 07/28/2022

Exponent to Announce Second Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on July 28, 2022

  • MENLO PARK, Calif., July 07, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2022 financial results for the period ended July 1, 2022 following the close of the market on Thursday, July 28, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 07/07/2022

Exponent to Present at Upcoming Investor Conferences

  • MENLO PARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the following investor conferences:
  • 05/23/2022

After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for Exponent (EXPO)

  • The heavy selling pressure might have exhausted for Exponent (EXPO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
  • 05/19/2022

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 19.9% in 4 Weeks

  • Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
  • 05/12/2022

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 16.5% in 4 Weeks

  • Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
  • 05/09/2022

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 14.6% in 4 Weeks

  • Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
  • 05/04/2022

Exponent, Inc. (EXPO) CEO Catherine Corrigan on Q1 2022 Results - Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO ) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Andrew Nicholas - William Blair Alexander Leach - Berenberg Capital Markets Tobey Sommer - Truist Securities Operator Good day and welcome to the Exponent, Inc. First Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded.
  • 04/30/2022

Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 7.69% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 04/28/2022

Exponent to Announce First Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on April 28, 2022

  • MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2022 financial results for the period ended April 1, 2022 following the close of the market on Thursday, April 28, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 04/04/2022

New Strong Sell Stocks for March 4th

  • AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022
  • 03/04/2022

Exponent, Inc. (EXPO) CEO Catherine Corrigan On Q4 2021 Results - Earnings Call Transcript

  • Exponent, Inc. (EXPO) CEO Catherine Corrigan On Q4 2021 Results - Earnings Call Transcript
  • 02/03/2022

Exponent (EXPO) Q4 Earnings and Revenues Beat Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 5.56% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 02/03/2022

Exponent to Announce Fourth Quarter and Fiscal Year 2021 Results and Host Quarterly Conference Call on February 3, 2022

  • MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report fourth quarter and fiscal year 2021 financial results for the period ended December 31, 2021 following the close of the market on Thursday, February 3, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 01/10/2022

Exponent (EXPO) Q3 Earnings and Revenues Surpass Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 15.00% and 3.83%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 10/28/2021

Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q2 2021 Results - Earnings Call Transcript

  • Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q2 2021 Results - Earnings Call Transcript
  • 10/28/2021

Exponent to Announce Third Quarter of Fiscal Year 2021 Results and Host Quarterly Conference Call on October 28

  • MENLO PARK, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report third quarter of fiscal year 2021 financial results for the period ended October 1, 2021 following the close of the market on Thursday, October 28, 2021. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 10/13/2021

4 Stocks Growing Earnings Fast

  • The S&P 500 saw its trailing 12-month real earnings per share increase by a compound annual growth rate of nearly 6% over the past five years. The index's share price ($4,432.99 as of Friday) has grown by more than 100% over the past five years.
  • 09/20/2021

Dividend Champion Highlights: Week Of September 19

  • weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
  • 09/18/2021

Exponent (EXPO): Strong Industry, Solid Earnings Estimate Revisions

  • Exponent (EXPO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
  • 09/01/2021

Are You Looking for a Top Momentum Pick? Why Exponent (EXPO) is a Great Choice

  • Does Exponent (EXPO) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 08/30/2021

Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q2 2021 Results - Earnings Call Transcript

  • Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q2 2021 Results - Earnings Call Transcript
  • 07/31/2021

Exponent (EXPO) Q2 Earnings and Revenues Surpass Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 14.29% and 6.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 07/29/2021

Exponent Declares Regular Quarterly Dividend

  • MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on September 24, 2021 to all common stockholders of record as of September 10, 2021.
  • 07/29/2021

Exponent to Announce Second Quarter of Fiscal Year 2021 Results and Host Quarterly Conference Call on July 29

  • MENLO PARK, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2021 financial results for the period ended July 2, 2021 following the close of the market on Thursday, July 29, 2021. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 07/13/2021

Exponent: Predicted Price Decline May Lead To A Buying Opportunity

  • Exponent: Predicted Price Decline May Lead To A Buying Opportunity
  • 06/17/2021

Exponent (EXPO) Sees Hammer Chart Pattern: Time to Buy?

  • Exponent (EXPO) has been struggling lately, but the selling pressure may be coming to an end soon
  • 05/24/2021

Tetra Tech: Continued Margin Expansion, U.S. Infrastructure Spending Provide Tailwinds

  • Tetra Tech: Continued Margin Expansion, U.S. Infrastructure Spending Provide Tailwinds
  • 05/09/2021

Exponent, Inc.'s (EXPO) CEO Dr. Catherine Corrigan on Q1 2021 Results - Earnings Call Transcript

  • Exponent, Inc.'s (EXPO) CEO Dr. Catherine Corrigan on Q1 2021 Results - Earnings Call Transcript
  • 04/30/2021

Exponent Reports First Quarter of Fiscal Year 2021 Financial Results

  • MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2021 ended April 2, 2021.
  • 04/29/2021

Earnings Preview: Exponent (EXPO) Q1 Earnings Expected to Decline

  • Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/22/2021

A Trio of Highly Profitable Business With Solid Conditions

  • In search of value opportunities, investors could be interested in the three stocks listed below, as they represent equities in companies with high profitability and robust financial conditions. These qualities are represented by GuruFocus profitability and financial strength ratings of at least 6 out of 10.
  • 04/20/2021

Exponent to Announce First Quarter of Fiscal Year 2021 Results and Host Quarterly Conference Call on April 29

  • MENLO PARK, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2021 financial results for the period ended April 2, 2021 following the close of the market on Thursday, April 29, 2021. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 04/08/2021

Dividend Challenger Highlights: Week Of March 21

  • A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends.
  • 03/21/2021

Exponent Inc: Continued Returns Expected Due To Robust Financial Foundation

  • This scientific consulting company is poised to provide ample shareholder returns within the next five years. The company's strong financial position will allow for these returns, and I will discuss relevant markers.
  • 03/10/2021

Exponent to Present at Upcoming Investor Conference

  • MENLO PARK, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the following investor conference:
  • 02/23/2021

Exponent CEO Joins Prestigious National Academy of Engineering

  • Dr. Catherine Ford Corrigan elected for leadership in biomechanical engineering and scientific consulting Dr. Catherine Ford Corrigan elected for leadership in biomechanical engineering and scientific consulting
  • 02/11/2021

Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q4 2020 Results - Earnings Call Transcript

  • Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q4 2020 Results - Earnings Call Transcript
  • 02/04/2021

Exponent (EXPO) Beats Q4 Earnings and Revenue Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 46.43% and 9.10%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 02/04/2021

Recap: Exponent Q4 Earnings

  • Shares of Exponent (NASDAQ:EXPO) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 13.89% year over year to $0.41, which beat the estimate of $0.28.
  • 02/04/2021

Exponent Reports Fourth Quarter and Fiscal Year 2020 Financial Results

  • MENLO PARK, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year 2020 ended January 1, 2021.
  • 02/04/2021

Exponent to Announce Fourth Quarter and Fiscal Year 2020 Results and Host Quarterly Conference Call on February 4

  • MENLO PARK, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report fourth quarter and fiscal year 2020 financial results for the period ended January 1, 2021 following the close of the market on Thursday, February 4, 2021. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
  • 01/14/2021

Exponent to Present at Upcoming Investor Conference

  • MENLO PARK, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the following investor conference:
  • 11/03/2020

Exponent, Inc. (EXPO) CEO Catherine Corrigan on Q3 2020 Results - Earnings Call Transcript

  • Exponent, Inc. (EXPO) CEO Catherine Corrigan on Q3 2020 Results - Earnings Call Transcript
  • 10/30/2020

Exponent Reports Third Quarter of Fiscal Year 2020 Financial Results

  • MENLO PARK, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter of fiscal year 2020 ended October 2, 2020.
  • 10/29/2020

Exponent Appoints George Brown to Board of Directors

  • MENLO PARK, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- ­­ Exponent, Inc. (Nasdaq:EXPO) today announced that it has appointed George Brown to its Board of Directors effective October 27, 2020.
  • 10/27/2020

Dividend Challenger Highlights: Week Of September 6

  • A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends.
  • 09/05/2020

Did Hedge Funds Make The Right Call On Exponent, Inc. (EXPO) ?

  • How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
  • 08/12/2020

Great Lakes Dredge And Dock: The 'Ry Cooder' Of Infrastructure Stocks (NASDAQ:GLDD)

  • Great Lakes Dredge is a 130-year-old company specializing in coastal and harbor dredging, and coastal restoration. It is the largest US dredging company.
  • 08/07/2020

Exponent, Inc. (EXPO) CEO Catherine Corrigan on Q2 2020 Results - Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO) Q2 2020 Earnings Conference Call July 30, 2020 04:30 PM ET Company Participants Whitney Kukulka - IR Catherine Corrigan - President & CEO Rich Schlenker - EVP & CFO Conference Call Participants Tobey Sommer - SunTrust Alexis Huseby - D.A.
  • 08/01/2020

Exponent (EXPO) Q2 Earnings and Revenues Surpass Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 40.91% and 3.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 07/31/2020

Exponent Reports Second Quarter of Fiscal Year 2020 Financial Results

  • MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter of fiscal year 2020 ended July 3, 2020. “We are pleased with the responsiveness of our employees and the adaptiveness of our company to today’s uncertain environment. Clients continue to call upon Exponent to address their challenges and to evaluate their opportunities, despite the rapid change and unpredictability that the pandemic has infused into their operating plans. While net revenues declined 12% in the second quarter, the fundamentals of our business remain strong and we continue to operate in a position of financial strength. We ended the quarter with $190 million in cash, cash equivalents and short-term investments, no debt, and reiterated our intent to continue quarterly dividends,” commented Dr. Catherine Corrigan, President and Chief Executive Officer.“The demand for Exponent’s interdisciplinary solutions is durable as companies continue to innovate and deploy increasingly complex products and systems. At the same time, society’s focus on safety, health, sustainability, and reliability requires rigorous science and data-driven analysis, which are hallmarks of Exponent’s more than 50 years of service. Our agility in assembling and deploying diversely skilled teams – drawing upon more than eight hundred highly credentialed consultants across a vast array of disciplines – has manifested itself yet again as we advise clients on a variety of issues prompted by COVID-19. Exponent has a long history and strong track record of delivering for all of our stakeholders, and we are confident in the resilience of our business and our ability to deliver growth over the long term,” continued Dr. Corrigan.Second Quarter Financial ResultsFor the second quarter of 2020, total revenues were $92.0 million, down 14% as compared to $106.5 million in the same period a year ago.  Revenues before reimbursements, or net revenues, were $87.9 million, down 12% as compared to $100.3 million in the second quarter of 2019.Net income for the second quarter of 2020 was $16.3 million or $0.31 per diluted share as compared to $21.0 million or $0.39 per diluted share in the same period of 2019.  The tax benefit for the classification of tax adjustments associated with share-based awards was $0.9 million in the second quarter of 2020 and $0 in same period last year.  Inclusive of the tax benefit, Exponent’s consolidated tax rate was 23.7% in the second quarter, as compared to 27.2% for the same period in 2019.EBITDA1 decreased to $22.8 million, or 26.0% of net revenue, as compared to $29.6 million or 29.5%, in the second quarter of 2019.Year to Date Financial ResultsFor the first half of 2020, total revenues decreased 4% to $198.0 million as compared to $205.5 million in the same period of 2019.  Revenues before reimbursements decreased 3% to $187.6 million as compared to $193.7 million in the same period one year ago.Net income for the first half of 2020 was $42.6 million, or $0.80 per diluted share, as compared to $43.7 million, or $0.81 per diluted share, in the same period of 2019.  The tax benefit for the classification of tax adjustments associated with share-based awards realized in the first half of 2020 was $9.7 million as compared to $5.7 million in the same period last year.  Inclusive of the tax benefit, Exponent’s consolidated tax rate was 6.2% in the first half of 2020, as compared to 16.2% for the same period last year.EBITDA1 decreased to $47.8 million, or 25.5% of net revenues, as compared to $53.4 million or 27.6% in the same period one year ago.In the first half of 2020, Exponent distributed $20.1 million in dividends, repurchased $40.0 million in common stock and closed the period with $190.2 million in cash, cash equivalents and short-term investments.In a separate press release today, Exponent announced a $0.19 quarterly dividend payment and reiterated its intent to continue to pay quarterly dividends. The Company also announced that its Board of Directors authorized an additional $45 million for future share repurchases.Business OverviewExponent’s engineering and other scientific segment represented 78% of the Company’s second quarter net revenues. Net revenues in this segment decreased 15% in the second quarter, as compared to 2019.  Business restrictions associated with COVID-19 caused project delays across multiple areas of the business. The most substantial impact occurred to our litigation support work for the transportation industry, with most assignments paused due to court-related delays. At the same time, we continued to see strength in integrity management advisory services for the utilities sector as clients focus on power reliability, in particular during the impending fire season in the western United States. Exponent’s environmental and health segment represented 22% of the Company’s second quarter net revenues. Net revenues in this segment decreased 2% in the second quarter, as compared to 2019. This segment also experienced delays in projects for the transportation and oil and gas industries. Within this segment, the chemical regulation and food safety practice continued to grow as Exponent’s scientists evaluated the effects of chemicals and new products on human health and the environment, including disinfectants for the novel coronavirus.Management Commentary and Response to COVID-19 Exponent responded quickly and carefully to address the unprecedented challenges created by the pandemic. We have successfully adapted and will continue to evolve our business development, recruiting and operational approaches, yielding benefits both during and after this crisis. We have accelerated our sharing of in-depth scientific and regulatory knowledge through webinars and thought leadership pieces, which has fostered new client relationships and projects. We have shifted all recruiting activities online, allowing us to reach a more geographically expansive set of candidates. The health and safety of our team remain top priorities, and therefore we have leveraged our internal expertise to establish protocols that allow us to safely continue laboratory activities and resume human participant studies. Our business continuity plan and robust infrastructure have empowered productive remote work, and employees continue to work from home unless they are performing laboratory testing or inspections. Our leadership team has responded with enhanced internal communications to encourage increased connectivity across the firm.We are pleased that Exponent has been able to effectively address our clients’ needs with a mostly remote workforce. The relaxation of business restrictions in June allowed us to resume laboratory testing, inspections, and human participant studies for clients in non-essential industries. Field inspections of sites and products have increased due to lifting of travel restrictions, but are still occurring at a reduced level since many businesses are not fully operational.  We successfully completed multiple human participant studies in June, utilizing our enhanced health and safety protocols. Demand for these studies continues to grow, but some are delayed because of uncertainty surrounding COVID-19 related restrictions. We remain optimistic about the long-term growth of this area.We continue to receive new retentions for litigation support, and work is ongoing for many existing matters. At the same time trial dates continue to be delayed, removing imminent deadlines and causing some clients – in particular the automotive industry – to pause work. Courts have been experimenting with virtual bench trials as well as social distancing for in-person trials, so we expect trials will gradually increase. We are pleased to be sharing our scientific and regulatory knowledge on health and safety issues related to the novel coronavirus. We have been engaged by clients to provide regulatory support in the United States and Europe as they register their new or existing disinfectant products. We have also been advising clients on occupational health and safety concerns including COVID-19 testing, contact tracing, and disinfecting as they strive to protect their employees, customers, and students. Furthermore, we have leveraged our breadth of disciplines from chemists and physicists to engineers to evaluate disinfectant products from hand sanitizers to ultraviolet light. Business OutlookAs society continues to raise its expectations for safety, health, sustainability and reliability, and products and processes continue to grow in their technological complexity, Exponent will evolve to stay ahead of the curve. These market drivers have powered Exponent’s growth for over 50 years and have led to increased demand for our interdisciplinary solutions despite periods of macroeconomic turbulence.“As a result of the current business, travel and physical distancing restrictions caused by the COVID-19 pandemic, net revenues for the first three weeks of the third quarter declined approximately 5% to 8% year-over-year. While there are opportunities for improvement, the high degree of uncertainty surrounding how and over what timeframe each region will impose or relax restrictions means that there could be further reduction to our revenues in the short term. Therefore, we cannot reliably provide financial guidance at this time,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer.“We have been nimble and pragmatic in our response to new market dynamics amid the unpredictable and rapidly evolving backdrop associated with COVID-19.  I am proud of our employees for responding with the same seriousness, intellectual rigor, and fact-based analysis that we have employed for over 50 years.
  • 07/30/2020

Analysts Estimate Exponent (EXPO) to Report a Decline in Earnings: What to Look Out for

  • Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/23/2020

Exponent, Inc.'s (NASDAQ:EXPO) Stock Is Going Strong: Is the Market Following Fundamentals?

  • Exponent's (NASDAQ:EXPO) stock is up by a considerable 12% over the past three months. Given the company's impressive...
  • 07/20/2020

Exponent to Announce Second Quarter of Fiscal Year 2020 Results and Host Quarterly Conference Call on July 30

  • MENLO PARK, Calif., July 09, 2020 -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2020 financial results for the period ended.
  • 07/09/2020

Analysts Estimate Exponent (EXPO) to Report a Decline in Earnings: What to Look Out for

  • Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/09/2020

Don't Buy Falling Financials, Buy These Stocks Instead

  • Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
  • 06/26/2020

Is Exponent, Inc. (EXPO) A Good Stock To Buy?

  • In this article we will take a look at whether hedge funds think Exponent, Inc. (NASDAQ:EXPO) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from […]
  • 06/24/2020

Insider Selling: Exponent, Inc. (NASDAQ:EXPO) Director Sells 8,000 Shares of Stock

  • Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 8,000 shares of the business’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $77.56, for a total value of $620,480.00. Following the transaction, the director now directly owns 71,627 shares of the company’s stock, valued at $5,555,390.12. The […]
  • 06/22/2020

Dividend Challenger Highlights: Week Of June 21

  • 06/20/2020

JPMorgan Chase & Co. Has $3.35 Million Stock Position in Exponent, Inc. (NASDAQ:EXPO)

  • JPMorgan Chase & Co. grew its position in Exponent, Inc. (NASDAQ:EXPO) by 46.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,529 shares of the business services provider’s stock after acquiring an additional 14,674 shares during the period. JPMorgan Chase & Co. […]
  • 06/19/2020

Dividend Challenger Highlights: Week Of June 7

  • A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies wi
  • 06/06/2020

Sidoti & Co. Maintains Buy on Exponent, Raises Price Target to $94

  • 06/02/2020

Exponent to Present at Upcoming Investor Conference

  • MENLO PARK, Calif., May 26, 2020 -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker,.
  • 05/26/2020

Exponent to Present at Upcoming Investor Conference

  • 05/26/2020

Shares of several industrial companies are trading lower amid market weakness following US unemployment data and recent cautious comments from the WHO. Sentiment is also negative following cautious comments from Fed Chair Powell and bearish outlook from some major US investors on Wednesday. Cautious economic sentiment has potentially hampered the outlook for industrial output and investment.

  • 05/14/2020

Sidoti & Co. Upgrades Exponent to Buy, Announces $80 Price Target

  • 05/13/2020

Buffettology's Three Categories of Moats

  • Our thoughts and picks Continue reading...
  • 05/07/2020

Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic

  • Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic
  • 05/07/2020

Exponent Issues Notice of Change in Location of Annual Stockholders’ Meeting to be Held on May 28, 2020 Due to COVID-19 (Virtual Meeting Format)

  • Exponent, Inc. (EXPO) today announced that due to current shelter in place orders in the San Francisco Bay Area and public health concerns regarding the COVID-19 pandemic and the welfare of our stockholders, employees, and other stakeholders, Exponent has decided to forego for this year the physical location of the 2020 Annual Meeting of Stockholders (the “2020 Annual Meeting”) to be held at 149 Commonwealth Drive, Menlo Park, California in favor of a virtual meeting format only, consistent with the proxy statement that we previously filed in respect of the 2020 Annual Meeting. As there will not be a physical location, stockholders will not be able to vote their shares in person at the 2020 Annual Meeting. The only way for stockholders to vote their shares is to submit a proxy in advance of the meeting using one of the methods described in the proxy materials for the 2020 Annual Meeting or to attend the meeting virtually per the instructions below.
  • 05/06/2020

Redwood Investments, LLC Buys Horizon Therapeutics PLC, NovoCure, Tetra Tech Inc, Sells Funko ...

  • 05/06/2020

Crown Advisors Management, Inc. Buys Onto Innovation Inc, ICU Medical Inc, Quidel Corp, Sells ...

  • 05/05/2020

Exponent, Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next

  • Last week, you might have seen that Exponent, Inc. (NASDAQ:EXPO) released its quarterly result to the market. The...
  • 05/03/2020

Analysts Offer Insights on Services Companies: Exponent (EXPO) and Altice Usa (ATUS)

  • Analysts have been eager to weigh in on the Services sector with new ratings on Exponent (EXPO) and Altice Usa (ATUS). Exponent (EXPO) Sidoti analyst Marc
  • 05/01/2020

Sidoti & Co. Maintains Neutral on Exponent, Raises Price Target to $80

  • 05/01/2020

Edited Transcript of EXPO earnings conference call or presentation 30-Apr-20 8:30pm GMT

  • Q1 2020 Exponent Inc Earnings Call
  • 05/01/2020

Exponent (NASDAQ:EXPO) Downgraded by BidaskClub to "Buy"

  • Exponent (NASDAQ:EXPO) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Friday, BidAskClub reports. A number of other equities research analysts have also weighed in on the company. Zacks Investment Research lowered Exponent from a “buy” rating to a “hold” rating in a research […]
  • 05/01/2020

Exponent Inc. (EXPO) Q1 2020 Earnings Call Transcript

  • EXPO earnings call for the period ending April 3, 2020.
  • 05/01/2020

Exponent's (EXPO) CEO Catherine Corrigan on Q1 2020 Results - Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corr
  • 05/01/2020

Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 11.36% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 05/01/2020

Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 11.36% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 05/01/2020

Exponent: 1Q Earnings Snapshot

  • MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported first-quarter net income of $26.3 million. The Menlo Park, California-based company said it had profit of 49 cents per share. The engineering and scientific consulting company posted revenue of $106 million in the period. Its adjusted revenue was $99.7 million. Exponent shares have increased nearly 2% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $70.33, an increase of 24% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXPO at https://www.zacks.com/ap/EXPO
  • 04/30/2020

Exponent: 1Q Earnings Snapshot

  • MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported first-quarter net income of $26.3 million. The Menlo Park, California-based company said it had profit of 49 cents per share. The engineering and scientific consulting company posted
  • 04/30/2020

Exponent Q1 EPS $0.490 Beats $0.420 Estimate, Sales $105.953M Beat $102.630M Estimate

  • 04/30/2020

Exponent Declares Regular Quarterly Dividend

  • Exponent, Inc. (EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock to be paid on June 26, 2020 to all common stockholders of record as of June 12, 2020. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors.
  • 04/30/2020

Exponent Declares Regular Quarterly Dividend

  • MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly...
  • 04/30/2020

Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates

  • 04/30/2020

Notable earnings after Thursday's close

  • AAPL, AEM, AJG, ALEX, AMGN, AMZN, ASGN, ATR, ATUS, BAND, BL, BLDR, BRKS, CDNA, CLGX, COG, COLM, CRY, CUZ, CXO, CXP, EBS, EGP, EIX, EMN, EXPO, FBHS, FHI, FMBI, FND, FTAI, FTV, FWRD, GILD, GLPI, HP, HTH
  • 04/29/2020

Business Services Apr 30 Earnings Roster: FCN, NLSN & More

  • Here's a sneak peek into how five business service stocks are placed prior to their earnings releases on Apr 30
  • 04/29/2020

Business Services Apr 30 Earnings Roster: FCN, NLSN & More

  • Here's a sneak peek into how five business service stocks are placed prior to their earnings releases on Apr 30
  • 04/29/2020

Exponent (EXPO) to Release Earnings on Thursday

  • Exponent (NASDAQ:EXPO) will be releasing its earnings data after the market closes on Thursday, April 30th. Analysts expect Exponent to post earnings of $0.44 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on […]
  • 04/28/2020

Stock Picking Is Key: Best Stocks To Buy Now

  • Individual stock picking is increasingly important. Energy and financials remain risky. Here are the top stocks to buy now.
  • 04/26/2020

Research Analysts Issue Forecasts for Exponent, Inc.'s Q2 2020 Earnings (NASDAQ:EXPO)

  • Exponent, Inc. (NASDAQ:EXPO) – Equities research analysts at SunTrust Banks decreased their Q2 2020 earnings per share (EPS) estimates for Exponent in a research report issued to clients and investors on Monday, April 20th. SunTrust Banks analyst T. Sommer now forecasts that the business services provider will earn $0.35 per share for the quarter, down […]
  • 04/24/2020

Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth

  • Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/23/2020

Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth

  • Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/23/2020

Top-Rated Stocks Near Buy Point With Earnings Due: Exponent

  • 04/23/2020

Introducing Virtual Vision Finance – The Ultimate B2B Fintech Expo

  • Registrations are now open for the latest shift to the virtual world of networking on June 10.
  • 04/22/2020

$99.68 Million in Sales Expected for Exponent, Inc. (NASDAQ:EXPO) This Quarter

  • Wall Street brokerages forecast that Exponent, Inc. (NASDAQ:EXPO) will report sales of $99.68 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Exponent’s earnings, with estimates ranging from $98.55 million to $100.80 million. Exponent posted sales of $93.40 million in the same quarter last year, which suggests […]
  • 04/21/2020

Video Trial on Fluoridation Chemicals Set for June 8 in Federal Court

  • Twice-delayed, a lawsuit seeking to prohibit the addition of fluoridation chemicals to public water systems in the U.S. because of the threat fluoride poses to the developing brain will begin June 8, reports the Fluoride Action Network (FAN).
  • 04/20/2020

Ladenburg Thalmann Financial Services Inc. Sells 604 Shares of Exponent, Inc. (NASDAQ:EXPO)

  • Ladenburg Thalmann Financial Services Inc. decreased its position in Exponent, Inc. (NASDAQ:EXPO) by 22.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,132 shares of the business services provider’s stock after selling 604 shares during the period. Ladenburg Thalmann […]
  • 04/20/2020

Does This Valuation Of Exponent, Inc. (NASDAQ:EXPO) Imply Investors Are Overpaying?

  • Does the April share price for Exponent, Inc. (NASDAQ:EXPO) reflect what it's really worth? Today, we will estimate...
  • 04/19/2020

6 Meridian Invests $583,000 in Exponent, Inc. (NASDAQ:EXPO)

  • 6 Meridian bought a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 8,108 shares of the business services provider’s stock, valued at approximately $583,000. Several other hedge funds also recently made changes to their positions […]
  • 04/16/2020

Top-Rated Stocks Near Buy Point Ahead Of Earnings: Exponent

  • 04/16/2020

Louisiana State Employees Retirement System Sells 3,430 Shares of Exponent, Inc. (NASDAQ:EXPO)

  • Louisiana State Employees Retirement System reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 19.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,270 shares of the business services provider’s stock after selling 3,430 shares during the period. Louisiana State Employees Retirement System’s holdings […]
  • 04/15/2020

7 Industrial Stocks To Buy For the Market Rebound

  • When the economy reopens, industrials will be the first sector to rebound as businesses re-up their spend on raw materials and energy.
  • 04/13/2020

Are Exponent, Inc. (NASDAQ:EXPO) Investors Paying Above The Intrinsic Value?

  • Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Exponent, Inc...
  • 04/13/2020

Exponent (NASDAQ:EXPO) Downgraded to Neutral at Sidoti

  • Sidoti lowered shares of Exponent (NASDAQ:EXPO) from a buy rating to a neutral rating in a research note issued to investors on Thursday morning, Briefing.com Automated Import reports. The firm currently has $78.00 price objective on the business services provider’s stock. EXPO has been the subject of a number of other research reports. Zacks Investment […]
  • 04/13/2020

Zacks Investment Research Lowers Exponent (NASDAQ:EXPO) to Hold

  • Zacks Investment Research downgraded shares of Exponent (NASDAQ:EXPO) from a buy rating to a hold rating in a report released on Wednesday morning, Zacks.com reports. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is […]
  • 04/12/2020

Norges Bank Makes New Investment in Exponent, Inc. (NASDAQ:EXPO)

  • Norges Bank purchased a new position in Exponent, Inc. (NASDAQ:EXPO) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 582,704 shares of the business services provider’s stock, valued at approximately $40,212,000. Other institutional investors and hedge funds also recently […]
  • 04/12/2020

Analysts Offer Predictions for Exponent, Inc.'s FY2020 Earnings (NASDAQ:EXPO)

  • Exponent, Inc. (NASDAQ:EXPO) – Equities research analysts at William Blair cut their FY2020 earnings estimates for Exponent in a note issued to investors on Monday, April 6th. William Blair analyst A. Nicholas now anticipates that the business services provider will post earnings per share of $1.53 for the year, down from their previous forecast of […]
  • 04/10/2020

Q2 2020 Earnings Estimate for Exponent, Inc. Issued By William Blair (NASDAQ:EXPO)

  • Exponent, Inc. (NASDAQ:EXPO) – Equities researchers at William Blair decreased their Q2 2020 EPS estimates for Exponent in a research report issued to clients and investors on Monday, April 6th. William Blair analyst A. Nicholas now anticipates that the business services provider will post earnings per share of $0.37 for the quarter, down from their […]
  • 04/10/2020

Exponent to Announce First Quarter of Fiscal Year 2020 Results and Host Quarterly Conference Call on April 30

  • MENLO PARK, Calif., April 09, 2020 -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2020 financial results for the period ended.
  • 04/09/2020

Exponent, Inc. (NASDAQ:EXPO) Receives Average Rating of "Buy" from Analysts

  • Shares of Exponent, Inc. (NASDAQ:EXPO) have earned an average recommendation of “Buy” from the eight brokerages that are covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective […]
  • 04/09/2020

Nuveen Asset Management LLC Sells 23,683 Shares of Exponent, Inc. (NASDAQ:EXPO)

  • Nuveen Asset Management LLC trimmed its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 3.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 584,847 shares of the business services provider’s stock after selling 23,683 shares during the quarter. Nuveen Asset Management LLC […]
  • 04/08/2020

Maybe We Can Climb The Great Wall Of Worry

  • The short- and long-term outlook is good, but mid-term risks are high. Here's what you can do now. Healthcare, consumer goods, and financials are the best secto
  • 04/07/2020

Geode Capital Management LLC Increases Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Geode Capital Management LLC boosted its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 828,673 shares of the business services provider’s stock after purchasing an additional 31,065 shares during the period. […]
  • 04/07/2020

Cubist Systematic Strategies LLC Grows Position in Exponent, Inc. (NASDAQ:EXPO)

  • Cubist Systematic Strategies LLC grew its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 138.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,383 shares of the business services provider’s stock after buying an additional 8,361 shares during the period. Cubist Systematic Strategies LLC’s […]
  • 04/06/2020

Earnings Season Preview: Exponent Near Buy Zone With EPS Due

  • 04/06/2020

Should You Be Adding Exponent (NASDAQ:EXPO) To Your Watchlist Today?

  • For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
  • 04/05/2020

Goldman Sachs Group Inc. Grows Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Goldman Sachs Group Inc. raised its position in Exponent, Inc. (NASDAQ:EXPO) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 148,449 shares of the business services provider’s stock after purchasing an additional 8,426 shares during the period. Goldman […]
  • 04/05/2020

Exponent, Inc. (NASDAQ:EXPO) Shares Sold by AQR Capital Management LLC

  • AQR Capital Management LLC lessened its position in Exponent, Inc. (NASDAQ:EXPO) by 5.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,247 shares of the business services provider’s stock after selling 1,558 shares during the period. AQR Capital Management LLC […]
  • 04/05/2020

Bank of New York Mellon Corp Decreases Stock Position in Exponent, Inc. (NASDAQ:EXPO)

  • Bank of New York Mellon Corp lessened its stake in Exponent, Inc. (NASDAQ:EXPO) by 12.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 651,446 shares of the business services provider’s stock after selling 94,560 shares during the quarter. Bank of […]
  • 03/31/2020

Has Exponent (EXPO) Outpaced Other Business Services Stocks This Year?

  • Is (EXPO) Outperforming Other Business Services Stocks This Year?
  • 03/30/2020

Has Exponent (EXPO) Outpaced Other Business Services Stocks This Year?

  • Is (EXPO) Outperforming Other Business Services Stocks This Year?
  • 03/30/2020

Archer Investment Corp Acquires New Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Archer Investment Corp acquired a new stake in Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 480 shares of the business services provider’s stock, valued at approximately $33,000. Several other hedge funds also recently modified their holdings of the stock. Riverbridge Partners […]
  • 03/30/2020

Is Aerojet Rocketdyne Holdings Inc (AJRD) A Good Stock To Buy?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 03/30/2020

Is The Descartes Systems Group Inc (DSGX) A Good Stock To Buy?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 03/30/2020

Has Exponent (EXPO) Outpaced Other Business Services Stocks This Year?

  • 03/30/2020

Brinker Capital Inc. Purchases 2,570 Shares of Exponent, Inc. (NASDAQ:EXPO)

  • Brinker Capital Inc. boosted its position in Exponent, Inc. (NASDAQ:EXPO) by 7.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 37,119 shares of the business services provider’s stock after acquiring an additional 2,570 shares during the period. Brinker Capital Inc. owned 0.07% of Exponent worth $2,562,000 […]
  • 03/28/2020

Exponent (NASDAQ:EXPO) Stock Price Up 15.4%

  • Exponent, Inc. (NASDAQ:EXPO)’s share price rose 15.4% during mid-day trading on Thursday . The stock traded as high as $69.13 and last traded at $68.46, approximately 381,831 shares traded hands during trading. An increase of 34% from the average daily volume of 284,761 shares. The stock had previously closed at $59.34. EXPO has been the […]
  • 03/28/2020

Embraer SA (ERJ): Are Hedge Funds Right About This Stock?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 03/28/2020

Hedge Funds Aren’t Crazy About National Health Investors Inc (NHI) Anymore

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 03/28/2020

Here is What Hedge Funds Think About Exponent, Inc. (EXPO)

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 03/28/2020

Stocks Flashing Renewed Technical Strength: Exponent

  • 03/27/2020

Advisor Group Inc. Acquires 367 Shares of Exponent, Inc. (NASDAQ:EXPO)

  • Advisor Group Inc. boosted its holdings in Exponent, Inc. (NASDAQ:EXPO) by 6.3% during the fourth quarter, Holdings Channel reports. The fund owned 6,193 shares of the business services provider’s stock after purchasing an additional 367 shares during the period. Advisor Group Inc.’s holdings in Exponent were worth $428,000 as of its most recent filing with […]
  • 03/25/2020

Dividend Challenger Highlights: Week Of March 22

  • A weekly summary of dividend activity for Dividend Challengers. Companies which declared increased dividends. Companies with upcoming ex-dividend dates. Compani
  • 03/21/2020

Why Exponent, Inc. (NASDAQ:EXPO) Looks Like A Quality Company

  • One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
  • 03/21/2020

Mercer Global Advisors Inc. ADV Invests $367,000 in Exponent, Inc. (NASDAQ:EXPO)

  • Mercer Global Advisors Inc. ADV purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,312 shares of the business services provider’s stock, valued at approximately $367,000. Other hedge funds have also […]
  • 03/21/2020

's Top Upgrades, Downgrades For March 19, 2020

  • Upgrades For Powell Industries Inc (NASDAQ: POWL), Sidoti & Co. upgraded the stock from Neutral to Buy. Powell Industries earned $0.24 in the first quarter,...
  • 03/19/2020

Sidoti & Co. Upgrades Exponent to Buy, Raises Price Target to $78

  • 03/19/2020

Exponent (NASDAQ:EXPO) Trading 7% Higher

  • Exponent, Inc. (NASDAQ:EXPO) traded up 7% during mid-day trading on Tuesday . The company traded as high as $66.98 and last traded at $66.38, 749,441 shares traded hands during trading. An increase of 189% from the average session volume of 258,937 shares. The stock had previously closed at $62.01. A number of analysts have recently […]
  • 03/19/2020

A Trio of High-Quality Stocks for the Value Investor

  • A Trio of High Quality Stocks for the Value Investor, Stocks: GNTX,EXPO,MRTN, release date:Mar 16, 2020
  • 03/16/2020

A Trio of High Quality Stocks for the Value Investor

  • A Trio of High Quality Stocks for the Value Investor, Stocks: GNTX,EXPO,MRTN, release date:Mar 16, 2020
  • 03/16/2020

A Trio of High Quality Stocks for the Value Investor

  • 03/16/2020

Exponent, Inc. (NASDAQ:EXPO) Given Consensus Rating of "Buy" by Brokerages

  • Shares of Exponent, Inc. (NASDAQ:EXPO) have earned an average recommendation of “Buy” from the eight research firms that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The […]
  • 03/15/2020

Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Bank of Montreal Can

  • Bank of Montreal Can increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 13.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,165 shares of the business services provider’s stock after purchasing an additional 1,428 shares during the period. Bank of […]
  • 03/15/2020

Great West Life Assurance Co. Can Buys New Stake in Exponent, Inc. (NASDAQ:EXPO)

  • Great West Life Assurance Co. Can bought a new stake in Exponent, Inc. (NASDAQ:EXPO) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 64,055 shares of the business services provider’s stock, valued at approximately $4,383,000. Great West Life Assurance Co. Can owned […]
  • 03/13/2020

Breathe - Here Are The Best Stocks To Buy Now

  • Markets are scary, but chasing returns is a losing strategy. Stocks are oversold, but margin remains a sharp-edged blade. Here are the top sectors and stocks no
  • 03/12/2020

Citigroup Inc. Has $2.79 Million Stock Position in Exponent, Inc. (NASDAQ:EXPO)

  • Citigroup Inc. grew its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 7.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,346 shares of the business services provider’s stock after acquiring an additional 2,806 shares during the quarter. Citigroup Inc. […]
  • 03/12/2020

Axiom International Investors LLC DE Has $6.81 Million Stake in Exponent, Inc. (NASDAQ:EXPO)

  • Axiom International Investors LLC DE lifted its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 15.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 98,745 shares of the business services provider’s stock after buying an additional 12,880 shares during the quarter. […]
  • 03/12/2020

Exponent (NASDAQ:EXPO) Shares Up 5.4%

  • Exponent, Inc. (NASDAQ:EXPO) shot up 5.4% during mid-day trading on Tuesday . The company traded as high as $79.33 and last traded at $79.15, 348,400 shares changed hands during trading. An increase of 55% from the average session volume of 224,204 shares. The stock had previously closed at $75.07. A number of brokerages have recently […]
  • 03/12/2020

Capital Analysts LLC Acquires New Shares in Exponent, Inc. (NASDAQ:EXPO)

  • Capital Analysts LLC acquired a new stake in Exponent, Inc. (NASDAQ:EXPO) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 2,630 shares of the business services provider’s stock, valued at approximately $181,000. Several other hedge funds have also added to or reduced their stakes in […]
  • 03/11/2020

Driehaus Capital Management LLC Has $2.79 Million Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Driehaus Capital Management LLC cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 20.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,428 shares of the business services provider’s stock after selling 10,430 shares during the quarter. Driehaus […]
  • 03/09/2020

Exponent, Inc. (NASDAQ:EXPO) Stock Holdings Increased by Envestnet Asset Management Inc.

  • Envestnet Asset Management Inc. lifted its stake in Exponent, Inc. (NASDAQ:EXPO) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 170,394 shares of the business services provider’s stock after purchasing an additional 6,954 shares during the quarter. Envestnet Asset Management Inc. […]
  • 03/09/2020

Urbem's 'Quality Strategy' Series: Reputation-Based Moat

  • A valuable intangible asset in the mission-critical space Continue reading...
  • 03/08/2020

Urbem€™s €˜Quality Strategy€™ Series: Reputation-Based Moat

  • Urbem’s ‘Quality Strategy’ Series: Reputation-Based Moat, Stocks: EXPO,ISRG,GGG,XPAR:GTT,ATRI,CLCT, release date:Mar 08, 2020
  • 03/08/2020

Dividend Challenger Highlights: Week Of March 8

  • A weekly summary of dividend activity for Dividend Challengers. Companies which declared increased dividends. Companies with upcoming ex-dividend dates. Compani
  • 03/08/2020

Exponent, Inc. (NASDAQ:EXPO) Looks Interesting, And It's About To Pay A Dividend

  • Readers hoping to buy Exponent, Inc. (NASDAQ:EXPO) for its dividend will need to make their move shortly, as the stock...
  • 03/08/2020

Exponent, Inc. (NASDAQ:EXPO) Looks Interesting, And It’s About To Pay A Dividend

  • It looks like Exponent, Inc. (NASDAQ:EXPO) is about to go ex-dividend in the next 3 days. You can purchase shares...
  • 03/08/2020

Urbem's 'Quality Strategy' Series: Reputation-Based Moat

  • 03/08/2020

Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Fmr LLC

  • Fmr LLC reduced its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 20.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 468,761 shares of the business services provider’s stock after selling 121,635 shares during the period. Fmr LLC owned approximately 0.90% of Exponent worth $32,349,000 at the […]
  • 03/07/2020

Exponent, Inc. (NASDAQ:EXPO) Shares Sold by C M Bidwell & Associates Ltd.

  • C M Bidwell & Associates Ltd. trimmed its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 14.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,065 shares of the business services provider’s stock after selling 180 shares during the […]
  • 03/06/2020

47 Upcoming Dividend Increases Including Coca-Cola

  • All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. 47 increases for next week (up from 22 las
  • 03/06/2020

February Performance Of The Concentrated High Growth Dividend Portfolio

  • My Concentrated High Growth Dividend Portfolio was down 6.0% in February while the S&P 500 was down 8.4% in February. The portfolio is down 4.7% year-to-date ve
  • 03/04/2020

Exponent (NASDAQ:EXPO) Upgraded to Hold at ValuEngine

  • Exponent (NASDAQ:EXPO) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, ValuEngine reports. A number of other equities analysts have also recently issued reports on the stock. Cantor Fitzgerald raised their price objective on shares of Exponent from $75.00 to $84.00 […]
  • 03/03/2020

Employees Retirement System of Texas Has $1.39 Million Stock Position in Exponent, Inc. (NASDAQ:EXPO)

  • Employees Retirement System of Texas reduced its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 35.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 20,082 shares of the business services provider’s stock after selling 11,000 shares during the quarter. Employees Retirement System of […]
  • 03/02/2020

Exponent (NASDAQ:EXPO) Rating Increased to Strong-Buy at BidaskClub

  • Exponent (NASDAQ:EXPO) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday, BidAskClub reports. Several other brokerages also recently issued reports on EXPO. Cantor Fitzgerald lifted their price target on shares of Exponent from $75.00 to $84.00 and gave the company an “overweight” […]
  • 03/02/2020

What Does Exponent, Inc.’s (NASDAQ:EXPO) P/E Ratio Tell You?

  • Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll apply a basic...
  • 03/01/2020

Charles Schwab Investment Management Inc. Grows Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Charles Schwab Investment Management Inc. boosted its position in Exponent, Inc. (NASDAQ:EXPO) by 1.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 366,110 shares of the business services provider’s stock after acquiring an additional 4,470 shares during the period. Charles Schwab Investment Management Inc. owned about 0.71% […]
  • 03/01/2020

Barclays PLC Raises Position in Exponent, Inc. (NASDAQ:EXPO)

  • Barclays PLC raised its stake in Exponent, Inc. (NASDAQ:EXPO) by 29.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 84,377 shares of the business services provider’s stock after purchasing an additional 19,088 shares during the quarter. Barclays PLC owned 0.16% of […]
  • 03/01/2020

Insider Selling: Exponent, Inc. (NASDAQ:EXPO) CFO Sells 60,149 Shares of Stock

  • Exponent, Inc. (NASDAQ:EXPO) CFO Richard L. Schlenker, Jr. sold 60,149 shares of Exponent stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $81.32, for a total value of $4,891,316.68. Following the completion of the transaction, the chief financial officer now owns 277,043 shares of the company’s stock, […]
  • 02/27/2020

2020 World Pork Expo set for June 3-5

  • The 2020 World Pork Expo is back at the Iowa State Fairgrounds for its 32nd year. The expo will take place on June 3 to 5, providing pork professionals with
  • 02/25/2020

Exponent Inc (EXPO) EVP & CFO Richard L Jr Schlenker Sold $4.9 million of Shares

  • 02/25/2020

Exponent (NASDAQ:EXPO) Raised to "Buy" at BidaskClub

  • BidaskClub upgraded shares of Exponent (NASDAQ:EXPO) from a hold rating to a buy rating in a research report report published on Thursday, BidAskClub reports. EXPO has been the subject of a number of other research reports. Zacks Investment Research raised shares of Exponent from a hold rating to a buy rating and set a $88.00 […]
  • 02/24/2020

Crossmark Global Holdings Inc. Has $435,000 Holdings in Exponent, Inc. (NASDAQ:EXPO)

  • Crossmark Global Holdings Inc. cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 8.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,310 shares of the business services provider’s stock after selling 610 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in […]
  • 02/22/2020

Los Angeles Capital Management & Equity Research Inc. Decreases Stake in Exponent, Inc. (NASDAQ:EXPO)

  • Los Angeles Capital Management & Equity Research Inc. reduced its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 6.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 95,017 shares of the business services provider’s stock after selling 6,571 shares during the period. Los Angeles Capital […]
  • 02/21/2020

My Market-Beating Portfolio: 41% Return In 2019

  • My high growth, low dividend yield long-term, tax-free portfolio has outperformed the S&P 500 every year for the past ten years, generating a 41% return in 2019
  • 02/21/2020

Stocks That Hit 52-Week Highs On Thursday

  • 02/20/2020

Stocks That Hit 52-Week Highs On Wednesday

  • 02/19/2020

Stocks That Hit 52-Week Highs On Tuesday

  • 02/18/2020

Have Exponent, Inc. (NASDAQ:EXPO) Insiders Been Selling Their Stock?

  • We'd be surprised if Exponent, Inc. (NASDAQ:EXPO) shareholders haven't noticed that the Group VP & Principal Engineer...
  • 02/15/2020

RK Capital Management, LLC Buys Echo Global Logistics Inc, Graco Inc, TPI Composites Inc, Sells ...

  • 02/14/2020

Exponent (NASDAQ:EXPO) Lifted to Buy at Zacks Investment Research

  • Zacks Investment Research upgraded shares of Exponent (NASDAQ:EXPO) from a hold rating to a buy rating in a research report sent to investors on Monday, Zacks.com reports. Zacks Investment Research currently has $88.00 target price on the business services provider’s stock. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and […]
  • 02/13/2020

Stocks That Hit 52-Week Highs On Thursday

  • 02/13/2020

Three Growth Stocks Tackling 5G’s Big Data Problem

  • For the past several years, as computing has gotten faster and more powerful, big data has been on the radar of many investors. What exactly is big data?
  • 02/11/2020

Edited Transcript of EXPO earnings conference call or presentation 6-Feb-20 9:30pm GMT

  • Q4 2019 Exponent Inc Earnings Call
  • 02/11/2020

2020 World Pork Expo set for June 3-5 in Des Moines

  • The 2020 World Pork Expo is back at the Iowa State Fairgrounds for its 32nd year. The expo will take place June 3 to 5, providing pork professionals with three
  • 02/11/2020

Exponent, Inc. Just Released Its Annual Earnings: Here’s What Analysts Think

  • Investors in Exponent, Inc. (NASDAQ:EXPO) had a good week, as its shares rose 7.7% to close at US$78.38 following the...
  • 02/10/2020

Exponent, Inc. Full-Year Results: Here's What Analysts Are Forecasting For Next Year

  • Investors in Exponent, Inc. (NASDAQ:EXPO) had a good week, as its shares rose 7.7% to close at US$78.38 following the...
  • 02/10/2020

Dividend Increases: February 1-7, 2020 (Part 2)

  • This article series provides a weekly summary of dividend increase announcements. A summary table provides relevant data and key statistics. Part 2 covers the D
  • 02/10/2020

Exponent Sees Its Composite Rating Rise To 97

  • 02/10/2020

Exponent (NASDAQ:EXPO) Price Target Raised to $74.00 at Sidoti

  • Exponent (NASDAQ:EXPO) had its price objective increased by Sidoti from $72.00 to $74.00 in a research report released on Friday morning, AnalystRatings.com reports. They currently have a neutral rating on the business services provider’s stock. EXPO has been the topic of several other reports. ValuEngine cut shares of Exponent from a sell rating to a […]
  • 02/08/2020

Exponent (EXPO) Receives a Hold from Sidoti

  • Sidoti analyst Marc Riddick maintained a Hold rating on Exponent (EXPO) today and set a price target of $74.00. The company's shares closed last Monday at
  • 02/07/2020

Exponent reports weak margins for Q4

  • Exponent (EXPO +0.8%) reports Q4 revenue growth of 19.5% Y/Y to $110.11M.Revenues before reimbursements were $102.2M (+19.5% Y/Y) & Reimbursements of $7.9M (+14.5% Y/Y).Operating margin declined 9
  • 02/07/2020

Exponent, Inc.'s (EXPO) CEO Dr. Catherine Corrigan on Q4 2019 Results - Earnings Call Transcript

  • Exponent, Inc. (NASDAQ:EXPO) Q4 2019 Results Earnings Conference Call February 6, 2020, 4:30 PM ET Company Participants Whitney Kukulka - Investor Relations Dr.
  • 02/07/2020

Sidoti & Co. Maintains Neutral on Exponent, Raises Price Target to $74

  • 02/07/2020

Exponent (EXPO) Surpasses Q4 Earnings and Revenue Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 9.09% and 6.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
  • 02/06/2020

Exponent (EXPO) Surpasses Q4 Earnings and Revenue Estimates

  • Exponent (EXPO) delivered earnings and revenue surprises of 9.09% and 6.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
  • 02/06/2020

Exponent: 4Q Earnings Snapshot

  • MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported fourth-quarter profit of $19.1 million. On a per-share basis, the Menlo Park, California-based company said it had net income of 36 cents. The engineering and scientific consulting company posted revenue of $110.1 million in the period. Its adjusted revenue was $102.2 million. For the year, the company reported profit of $82.5 million, or $1.53 per share. Revenue was reported as $391.4 million. Exponent shares have risen 7% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $73.94, a climb of 44% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXPO at https://www.zacks.com/ap/EXPO
  • 02/06/2020

Exponent: 4Q Earnings Snapshot

  • MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported fourth-quarter profit of $19.1 million. On a per-share basis, the Menlo Park, California-based company said it had net income of 36 cents. The engineering and scientific consulting c
  • 02/06/2020

Exponent Increases Quarterly Dividend Payment from $0.16 to $0.19 per Share

  • Exponent, Inc. (EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.19 per share of common stock to be paid on March 27, 2020 to all common stockholders of record as of March 13, 2020. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors.
  • 02/06/2020

Exponent Reports Fourth Quarter and Fiscal Year 2019 Financial Results

  • MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal...
  • 02/06/2020

Exponent, Inc. to Host Earnings Call

  • NEW YORK, NY / ACCESSWIRE / February 6, 2020 / Exponent, Inc. (NASDAQ:EXPO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 6, 2020 at 4:30 PM ...
  • 02/06/2020

Collectors Universe: An Easy-to-Understand 'Intangible Assets' Business

  • Well-moated and attractive return, with moderate growth and industry risks Continue reading...
  • 02/06/2020

Collectors Universe: An Easy-to-understand 'Intangible Assets' Business

  • Collectors Universe: An Easy-to-understand 'Intangible Assets' Business, Stocks: CLCT,EXPO, release date:Feb 06, 2020
  • 02/06/2020

Exponent (NASDAQ:EXPO) Downgraded to "Strong Sell" at ValuEngine

  • Exponent (NASDAQ:EXPO) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued on Tuesday, ValuEngine reports. Several other research analysts have also recently commented on EXPO. Zacks Investment Research upgraded Exponent from a “hold” rating to a “buy” rating and set a $75.00 price […]
  • 02/06/2020

Exponent Q4 EPS $0.36 Beats $0.33 Estimate, Sales $110.114M Beat $103.92M Estimate

  • 02/06/2020

ATFX Presents at International Forex Expo in Nigeria

  • This event was a first for ATFX in West Africa this year and we were very pleased to see the huge interest in Forex trading among the participants
  • 02/05/2020

Crown Advisors Management, Inc. Buys eHealth Inc, Arcosa Inc, Axonics Modulation Technologies ...

  • 02/05/2020

Exponent (EXPO) Scheduled to Post Earnings on Thursday

  • Exponent (NASDAQ:EXPO) is scheduled to release its Q4 2019 earnings data after the market closes on Thursday, February 6th. Analysts expect Exponent to post earnings of $0.33 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Shares of NASDAQ EXPO opened at $73.16 […]
  • 02/04/2020

Redwood Investments, LLC Buys QTS Realty Trust Inc, Brady Corp, Advanced Energy Industries Inc, ...

  • 02/04/2020
Unlock
EXPO Ratings Summary
EXPO Quant Ranking